Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study

Author(s):: Snoeren, N.; Hillegersberg, R. van; Schouten, S.B.; Bergman, A.M.; Werkhoven, E. van; Dalesio, O.; Tollenaar, R.A.E.M. (0000-0002-6831-6082); Verheul, H.M.; Sijp, J. van der; Rinkes, I.H.M.B.; Voest, E.E.; Hepatica Study Grp

Published: 2017
Publication type: Article / Letter to editor

Date issued: 2017-02-28
Language: English
Is part of: Neoplasia (2017), Vol. 19, no. 2, p. 93-99
hdl: 1887/95324
doi: 10.1016/j.neo.2016.08.010